Lycia Therapeutics, Inc. (NASDAQ:LYCA) IPO
IPO
Priced at US$18.00 a share on Oct 22, 2026.
- Price
- US$18.00 a share
- Shares offered
- 17,640,000 shares of common stock
- Offering size
- US$317.5 million
- Underwriters' option
- Up to 2,646,000 more shares
- Listing
- LYCA on the Nasdaq Global Select Market
- Underwriters
- Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities, LifeSci Capital · In the order on the cover
- Shares delivered
- On or about Oct 26, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 2, 2026 |
| Filed publicly | Oct 5, 2026 |
| Amended once | Oct 20, 2026 |
| Shares registered with an exchange | Oct 20, 2026 |
| Declared effective by the SEC | Oct 22, 2026 |
| Final prospectus, with the price | Oct 23, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 23, 2026 |
| EFFECT · Notice that a registration is effective | Oct 22, 2026 |
| S-1MEF · Registration of more shares for the same offering | Oct 22, 2026 |
| CERT · Exchange's certificate of listing | Oct 22, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 20, 2026 |
| S-1/A · Registration statement, amended | Oct 20, 2026 |
| S-1 · Registration statement | Oct 5, 2026 |
| DRS/A · Draft registration statement, amended | Aug 27, 2026 |
| DRS · Draft registration statement | Jul 2, 2026 |
From the cover of the final prospectus (424B4) filed Oct 23, 2026